Profound Medical Corp. Files 6-K with Press Release
Ticker: PROF · Form: 6-K · Filed: Jul 18, 2024 · CIK: 1628808
| Field | Detail |
|---|---|
| Company | Profound Medical Corp. (PROF) |
| Form Type | 6-K |
| Filed Date | Jul 18, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, press-release
TL;DR
Profound Medical Corp. filed a 6-K on 7/18/24, attaching a press release. Details likely inside.
AI Summary
Profound Medical Corp. filed a Form 6-K on July 18, 2024, to report a press release dated July 18, 2024. The filing itself does not contain specific financial details or operational updates beyond referencing the attached press release as Exhibit 99.1.
Why It Matters
This filing indicates Profound Medical Corp. is providing an update to investors, likely through the attached press release, which may contain material information about the company's operations or strategic direction.
Risk Assessment
Risk Level: medium — The filing is a routine 6-K, but the actual impact depends entirely on the content of the referenced press release, which is not detailed in the provided text.
Key Players & Entities
- Profound Medical Corp. (company) — Registrant
- July 18, 2024 (date) — Filing and Press Release Date
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report a press release dated July 18, 2024, as an exhibit.
What is the Commission File Number for Profound Medical Corp.?
The Commission File Number for Profound Medical Corp. is 001-39032.
Which exhibit is attached to this Form 6-K?
Exhibit 99.1, a Press Release dated July 18, 2024, is attached to this Form 6-K.
What is the principal executive office address of Profound Medical Corp.?
The principal executive office address is 2400 Skymark Avenue, Unit 6, Mississauga, Ontario L4W 5K5.
Does Profound Medical Corp. file annual reports under Form 20-F or Form 40-F?
Profound Medical Corp. files annual reports under Form 40-F, as indicated by the checkmark in the filing.
Filing Stats: 165 words · 1 min read · ~1 pages · Grade level 12.7 · Accepted 2024-07-18 16:45:04
Filing Documents
- f6k_071824.htm (6-K) — 5KB
- exh_991.htm (EX-99.1) — 5KB
- 0001171843-24-004023.txt ( ) — 12KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. PROFOUND MEDICAL CORP. (Registrant) Date: July 18, 2024 /s/ Rashed Dewan Rashed Dewan Chief Financial Officer